GlobalData on MSN
The Bayesian challenge: complexity that pays off
The FDA has released draft guidance on how sponsors can use Bayesian models for clinical trials.
Measuring Tumor Epichaperome Expression Using [124I] PU-H71 Positron Emission Tomography as a Biomarker of Response for PU-H71 Plus Nab-Paclitaxel in HER2-Negative Metastatic Breast Cancer For ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results